Episodes
-
For decades, rural areas have faced a steady decline—losing economic opportunities, grappling with the "brain drain" as creatives and young people migrate to urban centers, and watching local industries falter. But what if university Tech Transfer offices (TTOs) could reverse this trend and be the spark for rural revitalization? Today’s episode explores this potential with Dr. Richard Cahoon, an expert in the field who has over 30 years of experience in invention, intellectual property (IP) management, technology commercialization, and entrepreneurship.
Dr. Richard Cahoon, an Adjunct Professor in Global Development and former Director of Cornell’s Tech Transfer office, has worked extensively with universities, government agencies, and companies across more than 25 countries. In addition to advising on R&D partnerships, IP management, and venture creation, Richard is a seasoned innovator who holds several U.S. patents.
His vision? To align TTOs with Cooperative Extension offices and bring technology and entrepreneurship into rural communities to foster local talent, create sustainable businesses, and ultimately reshape these areas’ futures. Join us for this insightful conversation as Richard shares his strategies, lessons learned, and the transformative potential of connecting university resources with rural America.
In This Episode:
[02:04] Rural America has faced economic decline for decades, and traditionally, university tech transfer offices have focused more on urban or research-intensive areas.
[03:02] When Dr. Cahoon joined Cornell's Tech transfer office in 1990, he brought with him experience as an inventor and an entrepreneur. He was very involved in creating opportunities and recruiting entrepreneurs. He created the Venture Vision Summary which was like a tech brief.
[04:48] He wanted to take a proactive role in creating entrepreneurial activity in rural towns.
[06:10] Dr. Cahoon shares information about his first tech and entrepreneur pilot program in Auburn, New York.
[09:30] There was robust entrepreneurship at Cornell which helped with the pilot program that Dr. Cahoon was developing.
[10:19] How Tech Transfer professionals can help foster local talent retention through similar models.
[11:11] Thinking about the creative economy and creative people. Tech Transfer professionals are the bridge to enable the creative economy to flourish.
[12:56] He left the Tech Transfer office in 2009 just as it was beginning to thrive.
[13:41] We learn about a startup that came out of the Geneva campus at Cornell. It was about biological control of agricultural pests and disease.
[17:49] Dr. Cahoon made a connection with the owner of a car dealership while he was at Cornell. They ended up establishing a venture fund.
[18:51] Challenges when extending Tech Transfer models to a rural context.
[21:48] The importance of cooperative extension programs.
[24:09] Parallels between rural America's current situation and other countries or regions when fostering local innovation.
[25:55] How fortunate we are in the United States. Other countries have so much bureaucracy it's absolutely stifling.
[26:28] Key steps for growing this particular model at Cornell and other universities. It would be interesting to get a room full of Tech Transfer office directors and cooperative extension directors.
[28:13] It might be possible to start by getting Tech Transfer people together at AUTM.
[28:53] The AUTM 50th Anniversary meeting is coming up in March in Washington DC.
[29:11] Movements with impact often start with a small group.
[30:29] Dr. Cahoon shares the story about a small town that was once thriving because of technology and patents. This one is about the Channel Master TV antenna.
[32:05] This success can be reproduced with new technology.
[32:34] Practical advice for getting started and gaining traction in your local community. Reach out and look for technologies that might belong in a rural community. Do marketing with that in mind.
[35:08] How the TTO/Cooperative Extension could evolve. It has the potential to be one of the pillars of the mission of Tech Transfer.
Resources:
Dr. Richard Cahoon LinkedIn
Dr. Richard Cahoon
Dr. Richard Cahoon
-
In recent years, CRISPR technology has emerged as a game-changer in the world of gene editing, unlocking remarkable possibilities across various sectors, including healthcare, agriculture, and environmental science.
But what is CRISPR? CRISPR stands for "Clustered Regularly Interspaced Short Palindromic Repeats" and is based on an ancient function of prokaryotes—single-celled organisms such as bacteria and archaea. These organisms use a specialized CRISPR-associated molecule, Cas, to cut and destroy the DNA of invading viruses called bacteriophages.
The CRISPR-Cas system has been engineered to work in eukaryotes, like animals and plants. Its ability to make precise, targeted cuts in DNA sequences allows scientists to insert, delete, and modify DNA across a wide variety of cells. Among the various Cas proteins identified, the best known is CRISPR-Cas9, which has become a transformative tool in genome editing.
Given the potential value of this technology, the CRISPR patent landscape is vast. Some estimates suggest there are more than 12,000 families of patents related to CRISPR technology. Unsurprisingly, disputes have arisen over the ownership of these patents. Most famously, two groups have claimed rights to the use of CRISPR-Cas9 for eukaryotic gene editing: the University of California, Berkeley, the University of Vienna, and Dr. Emmanuelle Charpentier (CVC) on one side, and the Harvard-MIT Broad Institute on the other.
This dispute has led to several complex and lengthy battles in the U.S. Patent and Trademark Office, the European Patent Office, the Japanese Patent Office, the Chinese Patent Office, and in various courts, where proceedings are still ongoing.
Here to help us understand the latest developments in these ongoing disputes is Dr. Kevin Noonan. Kevin is an experienced patent lawyer, molecular biologist, and renowned thought leader in biotechnology and pharmaceutical patent law. He is a partner at the intellectual property law firm McDonnell Boehnen Hulbert & Berghoff, where he co-chairs the firm's Biotechnology and Pharmaceuticals Practice Group.
He is also the co-founder and regular contributor to Patent Docs, a website featuring news and commentary on patent law. In addition, he is a co-editor and contributing author of the book Claim Construction and the Federal Circuit, and a contributing author of Antitrust Issues in Intellectual Property Law, now in its second edition.
In This Episode:
[03:42] Dr. Noonan talks about how the Broad Institute and CVC became key players in the CRISPR patent landscape. Broad had very aggressively filed patents. CVC took a more laid back approach. Since the Broad patents were already filed they caused interference when the CVC patents came up.
[05:41] Broad had the earlier filing date.
[06:35] Dr. Noonan explains interferences.
[11:21] Eventually, the patents and applications may need to be decided in court.
[12:03] A summary of the main claims and inventions in the first interference. One had a more narrow claim to CRISPR.
[13:22] PTAP dismissed the first interference finding no interference.
[15:57] Interference number one was a victory to Broad.
[16:14] California wasn't happy with the first decision, so they filed a second interference.
[17:40] We learn about the rationale behind PTAB holding for Broad.
[21:55] The PTAB determined in the first interference that this was complicated and if it didn't work, they didn't really have conception.
[24:42] This is really an anomaly in interference law to have the second to conceive in the absence of these diligence issues, to have the second to conceive get the priority.
[25:14] Because it's so complicated, it's taking the Federal Circuit a long time to decide.
[26:22] Dr. Noonan shares how Broad should approach the case.
[27:32] There are four more CRISPR interferences involving Broad and CVC. Two involve Sigma Aldrich and the other two involve ToolGen.
[31:21] Dr. Noonan talks about what this means for the future of CRISPR research and applications and what tech transfer offices should be most aware of.
[34:42] Lessons that innovators, researchers, and tech transfer offices can draw from all of these interferences moving forward.
[39:35] The status of the Broad Institute and CVC's CRISPR-Cas9 patents in Europe.
[45:08] We discuss Sigma and ToolGen's patents in Europe.
[47:15] The status of the Broad Institute’s and CVC’s CRISPR-Cas9 patents in Japan and China.
[48:28] Final thoughts for Tech Transfer offices. It's a moving target, and as time goes by, there's more types of genetic interferences.
[49:45] The University of Missouri has gotten the first CRISPR pig patent in Europe. There's a proposed ban in Europe on selling CRISPR genetically modified plants.
Resources:
Dr. Kevin Noonan
Dr. Kevin Noonan LinkedIn
Patent Docs
-
Episodes manquant?
-
What if the next technology or scientific breakthrough is hidden in ancient tribal knowledge? Today, we'll look at Indigenous knowledge and intellectual property, and how Tech Transfer Offices deal with the specific issues of protecting and honoring these cultural assets.
We're delighted to welcome Graham Strong, Otago Innovation's commercialization manager with over 25 years of business expertise. Graham is an expert in both intellectual property and Indigenous rights, with a PhD in Botany and a Master of Laws focusing on the monetization of Māori medicinal knowledge.
As Otago Innovation's expert in natural product commercialization and Indigenous intellectual property, Graham is perfectly positioned to help us navigate this complex landscape.
We'll look at the underlying contrasts between Indigenous and non-Indigenous intellectual property systems, the problems of protecting Indigenous IP during technology transfer, and the importance of respectful interaction with Indigenous people.
We also look at how universities may form meaningful, long-term relationships that go beyond transactional agreements, ensuring that Indigenous perspectives are heard and their expertise is appropriately recognized and preserved during the innovation process.
In This Episode:
[01:44] Graham has a lot of expertise in both intellectual property and indigenous rights.
[02:02] Graham shares that traditional knowledge and indigenous IP are two different things.
[04:02] We talk about how universities can engage indigenous communities in a culturally respectful and meaningful way.
[05:01] Conversations can start when everyone realizes it's okay to be uncomfortable. Graham also talks about reputational damage.
[06:06] Key challenges when protecting indigenous IP in the context of text transfer.
[07:19] We talk about things like handling consent and ownership when traditional knowledge is embedded in new technology.
[08:14] It's difficult to protect background IP which is in the public domain. Graham talks about prior informed consent and mutually agreed terms. These are some of the ingredients that can be in place to handle consent of ownership.
[10:05] Drafting these types of agreements is still a work in progress for Graham's institution.
[11:32] The role that indigenous communities play in the decision-making about how they're knowledge is used.
[13:14] It's a balance between financial and non-financial when putting these partnerships together.
[15:45] We learn about the distinctions of which group you should engage in when looking for permission to use indigenous IP.
[18:33] Talking about cultural respect in tech transfer.
[20:33] We discuss whether universities are able to navigate these complexities while maintaining their core focus on research and innovation.
[23:02] Treating indigenous partners like any other partner and having a negotiation and seeing where it lands.
[24:38] Dealing with issues early on before money is involved.
[27:32] Graham shares a situation where involvement of indigenous communities has slowed down the commercialization of a technology.
[30:02] There have been times when there's been limited flexibility in developing commercialized technology with indigenous communities.
[32:03] We learn about how best practices in indigenous IP protection from other countries apply to universities in various legal, cultural, or economic contexts.
Resources:
Graham Strong - Otago Innovation
Graham Strong LinkedIn
-
The bourbon industry is a major economic driver for the Kentucky region, with 95% of the world's bourbon supply made and aged in the Bluegrass State. There’s more behind those barrels than aging whisky.
I’m joined by Dr. Greg Tucker , a licensing manager and commercialization specialist III at the University of Louisville. His extensive experience includes negotiating business terms for license agreements, managing university technologies, and establishing partnerships between innovators and companies. He holds a doctorate in chemistry from Arizona State University and has multiple U.S. patents in renewable energy.
We talk about the rich history of bourbon, exploring its origins dating back to George Washington and the evolution of its production process. We discuss how intellectual property plays a crucial role in the bourbon industry, from trademarks protecting iconic brands to patents safeguarding innovative distillation methods.
Greg also shares insights into notable IP cases, including the Jack Daniel's dog toy dispute and Maker's Mark's signature red wax seal. We also explore groundbreaking innovations emerging from the University of Louisville, with a spotlight on Bioproducts LLC. This company is revolutionizing the industry by transforming distillery waste into valuable products like animal feed, healthy sugar alternatives, and even materials for 3D printing.
Whether you're a bourbon enthusiast or just curious about how innovation impacts industry, this episode is for you. Grab your glass, sit back, and let’s toast to the history and future of bourbon.
In This Episode:
[02:17] Greg is the licensing manager at University of Louisville Research Foundation and the diversity and inclusion pillar lead for HIPAA, our Kentucky Intellectual Property Association here locally in Louisville.
[04:12] Bourbon is a 9 billion dollar industry in Kentucky.
[05:12] Greg shares the history of bourbon with us.
[07:29] What makes bourbon a bourbon is that the mash is at least 51% corn. It also has to be distilled and aged in an oak barrel.
[11:09] During prohibition people could still buy medicinal bourbon.
[11:40] September is also bourbon heritage month.
[12:13] You can still find George Washington's still at Mount Vernon.
[13:39] Tennessee whiskey is bourbon with an additional process.
[15:29] Greg talks more about what makes a bourbon a bourbon.
[16:31] The role that IP plays when it comes to bourbon. It touches every aspect from names and trademarks to copyrights and design patents.
[19:34] There are also a lot of bourbon trade secrets.
[21:13] Greg talks about Jack Daniels vs. VIP Products, where a Jack Daniels bottle replica was used as a dog toy. Maker's Mark also had a case involving the red signature wax that drips from the top of the bottle.
[25:23] Bioproducts transform organic waste from distilleries into value-added products.
[27:20] Stillage is the organic grainy waste leftover from the fermentation process. Some interesting uses have been for it from animal feed to sweeteners.
[30:07] There is also a company working on developing Biocoal.
[32:35] Greg talks about working with farmers and collaborations using biomass.
[34:31] The Estate Whiskey Alliance is trying to make the industry more efficient.
[36:05] Greg talks about using carbon credits and becoming more efficient.
[38:07] Challenges from scaling up with Bioproducts
[44:19] We learn about a quantitative method that can be used to identify the type of bourbon or whiskey due to its unique grain pattern.
[46:26] For Greg, bourbon tasting is not only work, it's a hobby too.
[47:46] Greg talks about his favorite bourbon and whiskey along with an IP story.
[53:44] This episode winds down with talking about favorite bourbons and sharing a virtual drink.
[55:57] Greg walks us through a traditional Kentucky bourbon tasting.
Resources:
T. Gregory Tucker, Ph.D. LinkedIn
Telpriore Greg Tucker Facebook
Bioproducts, LLC
-
AI is transforming the tech transfer industry, but how can we stay ahead of this rapidly evolving technology and fully leverage its capabilities? In this episode, we explore how AI is becoming an essential tool, helping accelerate licensing deals, identify the right industry partners, and market innovations more effectively.
To dive deeper into these advancements, we offer a sneak peek into our upcoming 4-week virtual course, The Future of Tech Transfer: Leveraging AI to Find & Secure Licensing Deals. This course is designed to equip you with practical AI skills that can revolutionize your approach to tech transfer.
It covers topics ranging from finding ideal industry partners to crafting personalized marketing strategies, all while emphasizing AI tools that boost efficiency and productivity in tech transfer offices. We also address the importance of adopting AI now to avoid falling behind in this fast-moving field.
Joining us are the course’s expert instructors: Peter Bittner, founder and CEO of The Upgrade, who has helped organizations like NASA and Apple close the AI skills gap, and Dr. D’vorah Graeser, founder and CEO of RocketSmart.io, a platform using AI to connect universities with top corporate partners.
In This Episode:
[02:14] This course is intended to look at AI from the perspective of a tech transfer professional. It's about using AI tools to make the process faster and more productive.
[03:37] AI tools can help innovations find the right commercial home and the right partner to commercialize the innovation and bring it to market.
[04:42] These tools will help tech transfer professionals find the right contact and make the right case.
[05:24] D’vorah talks about challenges for tech transfer offices finding corporate partners.
[06:42] Peter talks about the wide range of tools that they'll be covering in the course.
[10:32] D’vorah talks about how AI tools can help with invention summaries by defining the essence of the summary in regular language or from a business perspective.
[12:20] One way to craft a stronger pitch is to find the buyer side persona. Who is the buyer? How to identify the correct buyer persona?
[14:17] The pre-recorded modules of the live course will give everyone a foundation. The live part of the course will show how the tool can be used within specific contexts.
[15:13] There will be a pre-recorded module before every live module that corresponds to the content.
[16:40] Peter talks about how AI will allow all storytellers to do more with less.
[18:06] They're going to have office hours titled, Ask Us Anything About AI.
[20:04] D’vorah also encourages everybody to join the AI Special Interest Group. She also has a book coming out. They want to scale down AI for specific fields.
[22:51] D’vorah and Peter talk about the specifics of the modules and how busy people can fit the class into their schedules.
[24:34] Peter shares an AI success story and how AI enables a small team to be scrappier and more productive.
[27:21] How AI is going to evolve over the next 5 to 10 years and the possibilities of reducing friction.
[29:02] We talk about why tech transfer professionals should get involved in AI right now.
Resources:
The Future of Tech Transfer: 4-Week Virtual Training Course: October 15 – November 7
Peter Bittner - The Upgrade
Peter Bittner LinkedIn
Dr. D’vorah Graeser - Rocket Smart
Dr. D’vorah Graeser LinkedIn
-
Recent research has highlighted that patents from majority-female inventor teams receive significantly fewer citations—up to 22% less—than those from majority-male teams. Citations play a key role in measuring the impact and value of patents, making this gap significant not only for the inventors themselves but also for the broader innovation landscape.
Why are female inventors' patents cited less frequently, and how does this imbalance affect their future development and the total capacity for innovation?
Our guest today is Gauri Subramani, an assistant professor in Lehigh University's Department of Management. Gauri's research focuses on gender and resource disparity in innovation, using data-driven methods to identify gaps and investigate potential remedies.
Prior to joining academia, Gauri worked as a consultant and political appointee in the Office of Economic Policy at the United States Department of Treasury under the Obama administration. Her research spans the United States patent system and digital platforms, where she investigates the impact of representation on innovation and entrepreneurship.
One of the major topics we explore is the persisting gender discrepancy in patent citations, even after controlling for a variety of variables. We investigate whether this disparity is predominantly caused by applicant-added citations rather than examiner-added citations. Our discussion delves into the tendency of majority-male teams to regularly cite patents from other majority-male teams, as well as how patents from majority-female teams are less likely to be further developed.
We also look at how women's patent undercitation affects businesses that rely significantly on cumulative innovation, such healthcare and technology. Finally, our study contributes significantly to the continuing discussion about diversity, inclusion, and innovation in the field of patenting and intellectual property.
In This Episode:
[03:08] Patent citations are an established way by which researchers really measure the impact and quality of an invention. Gauri wanted to explore the gap in citations between female and male inventors.
[04:04] Female inventor teams received up to 22% fewer citations than male counterparts. Why does this citation gap exist?
[05:21] After implementing multiple controls in the study there's a 4% gap that they can't answer for.
[05:48] They've discovered that female inventors' patents are less likely to be cited and appear to be less likely to be further developed by subsequent inventions.
[06:59] This could mean that female inventor patents are less likely to be cited because they're less likely to be built upon. It's also possible that female patents could be perceived as less impactful.
[08:57] Citations are primarily added to patents by applicants or examiners.
[10:17] The gender gap seems to be driven entirely by applicant-added citations.
[11:22] Gender in-group preference appears to be a factor in patent citations.
[14:19] Technology areas with more female inventors grow more slowly. Female inventors' patents are also more distinct.
[15:26] We discuss how gender affects access to social networks that facilitate knowledge diffusion in the patent system.
[17:13] This gap could translate into other gaps and make less incentive for females to develop their inventions.
[19:08] Being less likely to build on inventions by female inventors exasperates several underlying problems especially in the healthcare and technology fields.
[20:39] There can be a desire to cite as little as possible on patent citations.
[22:23] Applicants and tech transfer offices should proactively think about the processes by which they search for and add citations.
[24:32] The Council for Inclusive Innovation is a signal of the USPTO's commitment to increasing diversity in patenting.
Resources:
Gauri Subramani
Gauri Subramani Lehigh University
Gauri Subramani LinkedIn
Untapped Potential: Investigating Gender Disparities in Patent Citations
Council for Inclusive Innovation
-
Artificial Intelligence (AI) is revolutionizing industries across the board, from healthcare to finance, bringing with it new challenges for inventors, universities, and the IP community. The U.S. Patent and Trademark Office (USPTO) recently issued new guidance on subject matter eligibility for AI inventions, providing much-needed clarity on how AI-related innovations can be patented. This update is vital for those working at the intersection of technology and intellectual property, especially in tech transfer offices and research institutions.
My guest today is someone deeply involved in shaping these policies: Derrick Brent, the Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the United States Patent and Trademark Office (USPTO). As Deputy Director of the USPTO, Derrick serves as the principal advisor to the Under Secretary of Commerce for Intellectual Property and Director of the USPTO, Kathi Vidal. In his role, Derrick works to advance intellectual property policies that foster innovation, support startups, and enhance entrepreneurship nationwide.
We discuss AI subject matter eligibility guidance and its impact on the future of AI patenting. Derrick shares that the goal of this guidance is to promote clarity and consistency for both USPTO staff and external stakeholders in analyzing AI and critical emerging technologies. The USPTO aims to streamline the patenting process for AI-related inventions through clarity and consistency to patent subject matter eligibility. We also cover where stakeholders can submit comments and feedback on these guidelines. Additionally, we explore the tools and resources available to help everyone become AI fluent to navigate this rapidly evolving landscape.
In This Episode:
[02:39] Derrick gives us a brief overview of the key updates in the USPTO's AI subject matter eligibility guidance.
[03:02] AI presents one of the greatest technological innovation opportunities in a generation. It's transformative and an amazing Innovation opportunity.
[03:32] Order 14110 or the Safe, Secure, and Trustworthy Development and Use of AI. Was used as a guiding principle.
[04:06] The guidance on the intersection of AI and IP, which could include patent eligibility issues related to innovation in AI and Critical Emerging Technologies was issued on July 17th of 2024. We are now in the middle of the comment period.
[04:12] There are three main parts to the guidance. The first part is to assist USPTO personnel and stakeholders in evaluating subject
matter eligibility for AI inventions.
[04:38] The second part of it is to provide a new set of examples to assist in applying guidance. The third part is to address feedback from stakeholders and also to discuss the law and policy landscape.
[06:40] Derrick shares information about the previous guidance that led up to this new guidance.
[12:19] The comment period is going on now, so submit your feedback regulations.gov.
[13:22] They are going to stay current with developments through engagement with stakeholders and interagency conversations and collaborations.
[15:41] Derrick shares important tools like Site Experience Education Program (SEE) and the Patent Examiner Technology Training Program (PETTP). The USPTO also has an AI portal.
[17:53] How the guidance addresses distinguishing between abstract ideas and practical applications.
[18:36] There is a two prong analysis. If the first prong is met then you move to the second prong.
[22:53] Use the tools with AI related patent applications. Be diligent and describe your invention as clearly as possible
[26:39] If you're interested in commenting, go to regulations.gov. The deadline for commenting should be in the portal.
[27:41] In spite of the type of IP, there is a consistency for the rules and guidelines of evaluation.
[29:49] Challenges include new and unprecedented inventions.
[30:56] Derick talks about government collaboration.
[33:14] AI is going to be a transformative problem solving tool.
Resources:
Derrick Brent
Derrick Brent LinkedIn
Journey to the USPTO — Derrick Brent, USPTO Deputy Director
Regulations.gov
Site Experience Education Program
USPTO Artificial Intelligence
-
The Manufacturing Extension Partnership (MEP) is a public-private partnership with centers in all 50 states and Puerto Rico. This episode dives into MEP and the MEP National Network—an initiative that has been a pillar of U.S. manufacturing, offering comprehensive solutions to manufacturers across the country and fueling growth and innovation in the sector.
Joining us for this discussion are two distinguished experts. First, we have Nagesh Rao, the acting director of the Manufacturing Extension Partnership at NIST. With over 25 years of experience across the public, private, and non-profit sectors, Nagesh brings a wealth of knowledge to the table. He previously served as Chief Information Officer for the Bureau of Industry and Security at the U.S. Department of Commerce, co-developed federal initiatives like i6 Green and Patents for Humanity, and led crucial technology efforts during the COVID-19 response.
David McFeeters-Krone is a commercialization and business development executive with over 25 years of experience at MIT, NASA-RTTC, Intel, and his own firm. He currently manages a Manufacturing Extension Partnership (OMEP) grant, engaging small manufacturers with the ManufacturingUSA institutes. David has reviewed numerous commercialization plans, founded two companies, and serves as an adjunct professor at Portland State University. He has established strategic R&D partnerships with organizations like the U.S. Air Force, NASA, and NIST, and was awarded the Federal Lab Consortium’s Outstanding Service Award in 2008.
In this episode, we’ll explore the MEP National Network’s role in supporting U.S. manufacturers, discuss innovative approaches to growth and competitiveness in the manufacturing sector, and gain valuable insights from Nagesh and David.
In This Episode:
[02:57] Nagesh shares how his background has led to innovation in the manufacturing sector.
[03:41] Nagesh started my career in technology transfer and commercialization back in 2002 at Rensselaer Polytechnic Institute.
[04:29] Coming to the MEP program in 2023 was a full circle journey of his career. He worked in engineering, public policy, the US patent and trademark office, then worked in industry and the national security space.
[05:07] He now ensures evidence-based policy decision making at the federal level to support small and medium-sized manufacturers.
[07:10] For our country to be competitive from a national security perspective we need a robust manufacturing scene.
[08:20] Challenges include keeping up with software demands and having a talented technical workforce.
[10:39] The role of MEP in helping small and medium-sized manufacturers navigate these challenges. MEP has a 30-year history of being a trusted advisor. They meet these manufacturers wherever they are.
[11:46] Collaboration ensures new technologies make it from the lab to the production floor.
[13:29] MEP is perfectly positioned to help companies overcome hurdles especially with connections. The role of the MEP Advanced Technology Team.
[15:11] How the MEP supports tech transfer in the manufacturing sector and the role for tech transfer Professionals in this ecosystem. MEP National Network is a network of networks within a greater network of innovation ecosystems across the United States.
[16:10] Think of an MEP center as a hub of excellence for a company that is in the business of manufacturing.
[20:08] Navigating the complex balance between academia and industry for a mutually beneficial relationship. Communication, culture, and contact.
[22:54] David shares examples of successful partnerships that led to significant advancements in manufacturing technology. One of the examples he uses is 3D printed plastic parts to service forms for metal press part making.
[26:02] Measuring the success of the MEP manufacturer initiatives.
[27:04] Common pitfalls manufacturers encounter when trying to bring about new technology. Lack of time and not realizing the value of partnerships are common.
[34:00] The government has done a tremendous amount of lift for many companies. Large companies know how to use the federal government.
[39:59] Predictions for where the MEP is going to go in the next 5 years.
[41:16] How making investments to move forward will help in the long run.
[46:49] Advice for getting involved in an MEP Network and supporting local manufacturers includes beginning with connecting with your local center and going to the MEP website on NIST.gov.
Resources:
NIST MEP
MEP National Network
Nagesh Rao
David McFeeters-Krone
David McFeeters-Krone LinkedIn
-
In a world where groundbreaking discoveries often struggle to leave the laboratory, we explore how to transform scientific insights into real-world solutions. We’re focusing on bridging the gap between academic research and community impact.
My guest today is Dr. Kendra Stenzel, the Director of Innovation Talent at the University of Kentucky's Office of Technology Commercialization. With her unique blend of scientific expertise and business acumen, Dr. Stenzel is at the forefront of training the next generation of entrepreneurs and commercialization professionals.
Armed with a Ph.D. in Pharmacology and an MBA with a focus on entrepreneurship, she serves as a vital bridge between researchers and the Tech Transfer office. Her mission? To help researchers reimagine their work through a commercialization lens, encouraging them to "fail fast and pivot" – a mantra that's reshaping how academic innovations reach the market.
She's also a facilitator, helping innovators develop business models, secure funding, and navigate the complex path from lab to market. Her experience with the Kentucky Network for Innovation and Commercialization (KYNETIC) has given her invaluable insights into nurturing early-stage innovations.
Today, we explore Dr. Stenzel's perspectives on how researchers can frame their outcomes to maximize community impact, the challenges of commercializing academic research, and her vision for the future of innovation in academia. Let's dive into this conversation about turning scientific breakthroughs into tangible benefits for society.
In This Episode:
[01:58] One of the main challenges with translating academic research into community impact is education.
[02:37] Common misconceptions and challenges include some innovators not understanding that their innovations aren't market ready or community ready and getting innovators to understand the word commercialization.
[04:20] The goal is beyond making money, it's having an impact on the community. Getting innovators to accept this reality has a lot to do with being intentional with the relationship.
[06:00] Balancing the academic focus on research and the need for commercialization includes relating with the researcher and investing in the relationship. Meeting the researchers in the lab and having the conversation about the science and defining the research and outlining the path forward.
[07:10] Barriers that prevent research from making it out of the university include lack of time, having all of the necessary qualifications, and having the knowledge and support.
[09:35] From the start they focus on things like the regulatory pathway, prototyping, and the facilities they have to use. Launch Blue has an innovation training program and programs that keep innovators engaged.
[10:46] Kendra talks about crucial elements of a successful education program for researchers.
[12:09] thinking outside the box and communicating that everyone can be an innovator.
[12:53] Money to put towards proof-of-concept development is crucial. The education and framework brought to the innovator is also very important.
[14:56] Collaboration and cultivating partnerships that align with university goals and needs of the broader community.
[16:44] Measuring the long term impacts of intellectual property assets. Defining success goes back to understanding stakeholders. They do have quantitative metrics to protect intellectual property assets. Kendra likes to look at the qualitative metrics and the innovator and the team.
[19:16] The MBA that Kendra is getting has really taught her to think in terms of strategy.
[20:43] Advice includes meeting innovators where they are and keeping relationships first.
Resources:
Kendra Stenzel Director, Innovation Talent Development UK
Kendra Stenzel University of Kentucky
Kendra Stenzel LinkedIn
-
Did you know that despite being behind many groundbreaking inventions and patents, women are less likely to turn their ideas into commercial products? It's a trend that's holding us back, and we're here to explore why. To discuss the experiences and insights of leading women scientists, researchers, and inventors. We have two prolific and leading women with us today.
Dr. Marianne Privett, is a Partner and patent attorney with extensive knowledge in chemistry and materials science. Marianne manages patent portfolios for a diverse range of clients, including multinationals and universities, with a focus on clean tech. She's a strong advocate for women inventors and entrepreneurs and actively participates in networks like Women in Health Tech and the Global Women Inventors & Innovators Network.
Dr. Aardra Kachroo, a Professor at the University of Kentucky specializing in plant pathology. Her research delves into the intricate signaling mechanisms in plants, particularly how they adapt and respond to various pathogens. Aardra has received numerous awards for her work and is deeply involved in outreach, including workshops for youth and presentations to farmers.
In This Episode:
[02:18] Marianne shares her journey in science and innovation. She discovered that patents were a good way to marry business with science.
[03:26] Aardra always loved science, and she's a researcher. She didn't want to work with animals so she chose plant research. She has two patents and a company based on one of those.
[05:12] Challenges that women inventors face navigating the IP landscape. Research shows that women aren't engaging as much with the patent process.
[06:59] There are fewer girls and young women studying STEM subjects.
[08:13] We need to have uncomfortable conversations about why women aren't showing up as inventors.
[08:32] Aardra shares her patent experience. Her company was patented by her husband. She refers to studies where women want everything to be 100% where a man is more confident and will go ahead before the project reaches that point.
[09:38] Women being unwilling to commercialize their innovation because of perfectionism.
[10:21] Women also seem to face more barriers than a man in the same position.
[12:05] The low percentage of women that get VC funding is scary. Role models also have something to do with this. We need to normalize women entrepreneurs.
[14:04] Aardra talks about outreach contributing to the commercialization of research. She shares a story about how what she was doing in the lab was able to make it into society.
[16:35] It's easier for a student to understand what you're studying if you show them that it's applicable in the real world.
[18:44] Marianne talks about networking groups such as Women in Health Tech and the Global Women Inventors & Innovators Network.
[21:44] She also shares global innovation advice for women to protect their inventions.
[25:10] Opportunities on the horizon for women inventors. The CHIPS and Science Act creates a more streamlined pathway to innovation and commercialization. There's also a lot of focus on supporting women and minorities.
[26:59] Technology, Innovation and Partnerships (TIP) has funding programs for every step of the way.
[28:19] The UK also has similar programs just on a smaller scale.
[29:35] How tech transfer professionals can better support women.
Resources:
Dr. Marianne Privett
Dr. Marianne Privett LinkedIn
Dr. Aardra Kachroo
Dr. Aardra Kachroo LinkedIn
-
Tech Transfer professionals have a lot to stay on top of, including the legislative and legal landscape in Washington, DC. My guest today is Jeffrey Depp, who shares his expert knowledge on the current cases we should be aware of.
Jeffrey is a registered patent attorney with extensive experience in intellectual property and innovation policy. His diverse background spans university Tech Transfer, the pharmaceutical industry, law, and the federal courts. Currently pursuing his PhD at the University of Pittsburgh, Jeffrey applies an Austrian economics lens to U.S. innovation, bringing a unique perspective to our discussion.
In addition to his academic pursuits, Jeffrey consults on biopharmaceutical innovation for the Center for Strategic and International Studies. His commitment to shaping policy is evident through his active involvement in various professional organizations, including his current membership and former role as chair of the Public Policy Legal Task Force at AUTM.
In today's episode, we'll explore Jeffrey's rich background and how it influences his current work. We'll provide an overview of this year's comment requests from Washington, DC, discuss the administrative landscape affecting Tech Transfer, and examine recent Supreme Court decisions, including Loper Bright v. Raimondo and SEC v. Jarkesy, and their implications for the tech transfer field.
We also look at key decisions in the federal courts and Congress. Jeffrey breaks down these cases and explains their relevance to us, while also sharing tips for tech transfer professionals to stay informed.
In This Episode:
[01:57] Jeffrey works with a number of organizations in DC trying to promote the progress of science through technology and commercialization.
[02:20] He has real world experience and formal training. He spent many years in the pharmaceutical industry and in university technology transfer. He has an MBA. He's a registered patent attorney. He's working on a PhD dissertation focused on the nature and causes of American innovation from an Austrian economics perspective.
[03:50] We learn why it's important for tech transfer professionals to stay updated on the legislative activities happening in DC. Staying on top of legislation is just another job that tech transfer professionals have to do.
[05:21] Bad policy can devour even the best of science. This is why Jeffrey has gotten involved to help great technology move forward instead of being stifled by bad policy.
[06:47] We try to keep our eye on three buckets, the administrative law side of it, what's going on in Congress with legislation, and of course, what the courts are doing.
[07:28] This year has been extremely active with nine or so comments requested from agencies.
[08:13] The USPTO has put out guidance about who is the inventor when it comes to AI technologies. There has to be sufficient human inventorship in order to be patentable.
[10:05] The patent office asked for comments about how to promote more innovation in the marketplace. There were also fee increases.
[14:44] Jeffrey talks about more of the comment request issues this year.
[17:31] There's another one about the impact of AI on prior art. The human being needs to be paramount in inventorship.
[22:29] The last one is about the experimental use exception.
[24:43] SEC v. Jarkesy referenced the Oil States case which did directly implicate intellectual property issues.
[28:19] Jeffrey talks about the private rights public rights doctrine of patents.
[29:01] Jeffrey talks about Loper Bright v. Raimondo.
[30:45] We discuss pending cases in the Supreme Court that we should keep an eye on including Cellect, LLC v. Vidal.
[31:21] This case is very important for tech transfer professionals to be following. The case establishes binding
precedent that a terminal disclaimer cuts off any extended patent term granted through PTA.
[38:28] Jeffrey shares his thoughts on some of the key decisions in the federal circuit court. Including the LKQ Corp. case which affects design patents.
[41:29] We also talk about University of California v. Broad Institute Inc. regarding CRISPR technology. This is important because gene editing is only going to continue to grow in creating health breakthroughs.
[45:28] We talk about the legislative side. Congress has introduced multiple patent bills including the Prevail Act, the Patent Eligibility Restoration Act, the Restore Act, RALIA, and the Balancing Incentives Act.
[46:16] Problems with the patent system include things that make patents unreliable and things that make patents uncertain.
[53:47] Jeffrey talks about the Countering Communist China Act and the Invent Here, Make Here Act.
[58:42] We discuss the FTC's move to ban non-compete agreements and how this could affect technology transfer offices.
[01:02:53] The best way to stay on top of things is to compartmentalize it in your mind and keep an eye on what's going on in the courts and the federal circuit. The Judiciary Committee has a subcommittee focused on IP. Also focus on the USPTO and the NIH.
Resources:
Jeffrey Depp LinkedIn
SEC v. Jarkesy
Loper Bright v. Raimondo
LKQ Corp case v. GM
Countering Communist China Act
Invent Here, Make Here Act
-
Innovation is at the heart of both Tech Transfer and human progress. It's in our nature to seek better ways of implementing ideas, but historically, innovation hasn't always received the scholarly attention it deserves, despite technology being integral to our lives—think of the 250,000 patents in a single smartphone.
I’m thrilled to have Joy Goswami, Senior Director of Corporate Engagement at Johns Hopkins University, here to talk about the role of Technology Transfer in fostering innovation, distinguishing between invention and innovation, and exploring how tech transfer professionals categorize, assess, and commercialize new inventions.
We'll discuss how the invention process begins with disclosure, followed by classification into sustaining, disruptive, and breakthrough technologies, among others. Disruptive innovations, in particular, create entirely new markets. We'll also touch on inspiring stories, like the invention of a glass keyboard for people with disabilities that became part of the iPhone, and a nurse's passion that led to a startup for wearable simulators.
As we look to the future, trends such as interdisciplinary research, entrepreneurship, and emerging technologies like AI, machine learning, cybersecurity, and biotechnology will shape the landscape of innovation. Join us to get an inside look into the power of innovation and the bright future of Tech Transfer.
In This Episode:
[02:10] Innovation is the cornerstone of what Tech Transfer professionals do. It's also the cornerstone of human development in general. It's our nature to seek new and improved ways of putting ideas into action.
[03:02] Innovation hasn't always received the scholarly focus that it deserves. Yet, technology is everywhere. There are 250,000 patents in our cell phone alone.
[05:02] Today we're going to talk about Technology Transfer in the role of innovation in Technology Transfer.
[05:16] The distinction between invention and innovation. Inventions are solutions to problems. Innovation is a commercially successful use of invention.
[06:22] The starting point is an invention disclosure.
[08:06] We chop up the invention disclosure in different segments and plug it into an assessment knowledge canvas.
[08:32] There are three broad categories to understanding innovation: understanding the innovation, the classification of the innovation, and additional details broken into 10 different subparts.
[09:32] We want to take the innovation from the point the inventor has given us to commercializing.
[10:14] Four kinds of patent protection including process, composition of matter, articles of manufacture, and machines.
[11:23] Classification also has four classes including sustaining, discontinuous, disruptive, and breakthrough technologies.
[12:16] Disruptive is critical, because it's the one that creates new markets.
[13:36] Tech Transfer professionals have a lot of responsibility with categorizing the Invention from the beginning and making sure that it has a value proposition.
[14:11] Crucial mindset for academic researchers to foster innovation. Academics are moving from doing the research and sharing knowledge to research that has an impact on society.
[17:35] There are translational researchers who love working in the translational space. They can be used as ambassadors to coach the next generation. Education about the process and benefits of tech transfer is crucial for innovation.
[19:32] Joy shares some personal experiences that highlight the power of mindset when it comes to innovation.
[21:19] The story of a keyboard developed on glass which was meant for people with disabilities. The inventors were able to sell the patent for this to Steve Jobs and it was integrated into the iPhone.
[23:03] The impact and passion that these inventors had led to success.
[24:28] A nurse who developed a wearable simulation device for training healthcare practitioners was so passionate that it became a startup called Avkin that makes wearable simulators.
[25:56] Johns Hopkins University is one of the oldest universities established in 1876. It was also one of the first universities to have research as a component. They now do $3.4 billion dollars of research. They get more than 400 disclosures a year.
[27:21] The Tasty Tape is a tape that holds a burrito together. It's simple and yet it was complicated. Hopkins also developed the targeted real-time early morning system or TREWS.
[28:41] Saccharin, rubber gloves used by surgeons, and the smart tissue autonomous robot STAR have been developed by Johns Hopkins.
[29:41] Exciting trends in academic transfer that boost innovation include integrated technology in the process. The world's getting smaller and everything's at a global scale.
[32:11] There's an increased focus of interdisciplinary research not just in the US but globally. Universities are also developing consortium models. There's also a growing emphasis on entrepreneurship and startup culture.
[35:07] Practical steps to create a culture that encourages and awards innovation amongst faculty and researchers. They need to be treated with a little TLC, because they do multi-functional work with education and research. We also need to continue to educate the faculty members.
[38:53] Emerging trends and technology shaping the future include AI and machine learning. Other emerging trends include cybersecurity, biotechnology, genomic space, and personalized medicine, and CRISPR technology.
[40:23] 3D printing, electronics, healthcare, energy manufacturing and data science are also sectors to watch.
[41:24] Things are going to become more complicated and sophisticated as we move forward.
Resources:
Joy Goswami, Senior Director of Corporate Engagement at Johns Hopkins University
Joy Goswami LinkedIn
Joy Goswami Twitter
Partners in Discovery: Unlocking the Potential of Research Collaborations With Gaylene Anderson
-
Let’s take a deep dive into innovation in the health sector and the role that university research plays in this sector. Joining us today is Richard Gannotta, a seasoned healthcare executive with a remarkable career spanning top academic and public health systems.
From leading UC Irvine Health to shaping policy at NYC Health + Hospitals, Rick's expertise is unparalleled. As managing partner of Washington Square Advisors, he continues to drive innovation in the medtech and biotech industries. He's also a dedicated educator at NYU and the host of the Healthcare Nation podcast.
In this episode, we explore the future of healthcare and technological development. We'll explore how telehealth is transforming patient care, the groundbreaking potential of AI in medicine, and the critical role of intellectual property in driving innovation.
We'll also discuss the evolving landscape of healthcare delivery, the impact of new technologies like wearables, and the policies needed to support this exciting transformation. Join us as we uncover the trends shaping the future of health and wellness.
In This Episode:
[02:16] Rick shares his amazing career journey. According to Rick, he's just a kid from Brooklyn who caught a couple of good breaks along the way.
[02:46] He's always been interested in technology, science, and medicine.
[03:17] He ended up dropping out of high school and becoming a nurse's aide and then an LPN. This was a big break for him. It eventually led to nursing school, becoming a nurse practitioner, and getting a degree. He now has an MBA and a doctorate in healthcare policy.
[04:33] Starting out working at the bedside was invaluable information for his further career. He's also always taught academically. His firm Washington Square Advisors is a boutique firm navigating the intricacies of the healthcare sector.
[06:26] Career paths aren't linear. They can have many twists and turns.
[06:54] Rick believes that technology is the new biology. It will be equally important for the health and wellness of society and individuals.
[08:03] Validating ideas and whether the innovation is addressing the issue.
[10:17] Three Factor Framing. There are three factors that are the key components of disruptive innovations. The first Factor F1 is really market eligibility or ideation. Is there demand?
[12:14] F2 is the governing process. The environmental gating conditions that would slow things down or speed them up.
[12:56] F3 is the out of field variable or the X factor. It's an approach or technology commonly used in a different sector.
[14:05] These can be applied to idea generation, brainstorming and more.
[16:15] Rick talks about Telehealth and AI revolutionizing healthcare. There are incredible opportunities to change the game.
[18:02] Rick predicts a convergence of The Internet of Things and medical technology.
[20:14] The first rule at Washington Square Advisors is to seek to understand your client's challenges. Work closely with the teams to understand the philosophy.
[23:18] Rick talks about navigating IP challenges working with startups in the healthcare sector. It's essential to secure your patent early.
[27:44] Governmental policies are very important when you're thinking about startups.
[28:19] Can we make healthcare better, more convenient, and more accessible using technology? Another big issue is the medical professional shortage.
[32:46] Strategies for tech transfer offices include having strong relationships with industry partners, having your finger on the pulse of what's happening, and understanding the resources that you need to provide.
[34:33] Partnership agreements and joint ventures make a lot of sense.
[35:16] Pitfalls include not fully understanding or underestimating hurdles such as regulatory issues. Inadequate market understanding, fit, and validation are also concerns that need to be addressed.
[36:43] All of the processes begin with education.
[37:47] Rick's advice includes focusing on understanding the real clinical need and the why.
Resources:
Richard Gannotta NYU Wagner
Richard Gannotta LinkedIn
Healthcare Nation Podcast
-
Navigating the intricacies of university-industry partnerships is more important than ever in an era when colleges increasingly see their intellectual property portfolios as attractive sources of prospective revenue. Today, I'm thrilled to have Donald Siegel join us to talk about university-industry partnerships, as described in his book The Chicago Handbook of University Technology Transfer and Academic Entrepreneurship.
Don is a Foundation Professor of Public Policy and Management at Arizona State University and Co-Director of the Global Center for Technology Transfer. With a remarkable career that includes serving as Dean of the School of Business at the University at Albany, SUNY, and editing prominent journals such as the Journal of Technology Transfer, he has unrivaled knowledge of university technology transfer and academic entrepreneurship.
Don and his co-editors have prepared a thorough guidebook that synthesizes cutting-edge research and gives critical insights from experts across many fields. Today, we'll look at key themes from the book, including the evolution of technology transfer, intellectual property management systems, and how to foster an entrepreneurial culture within universities.
In This Episode:
[02:14] All of the authors are academics that have been studying Tech Transfer. They've seen the field evolve as an academic field. It's a global phenomenon and people in multiple disciplines have been studying this field.
[03:06] They decided to approach the University of Chicago Press and pitch their idea. It was a difficult sale, because they've never done a handbook or anything on tech transfer.
[04:36] It's a collection of leading edge research on the topic.
[05:04] One of the chapters is an entrepreneur's guide to the university. Open innovation is one of the important concepts.
[06:40] One of the major changes that Don has seen are people with business and entrepreneurial experience in the Tech Transfer office.
[07:39] They've moved beyond licensing and patenting with a greater focus on entrepreneurship.
[09:22] There's also a much greater appreciation of the role of technology and economic development.
[11:20] Don talks about how AUTM has changed and how they have more real world professionals with business experience. There's a strong entrepreneurial component to what Tech Transfer does.
[12:44] Tech Transfer offices also play a very important role in educating faculty and administrators about the value of Tech Transfer.
[15:01] Social returns to basic research maximize the value to the economy and society.
[16:55] Tech Transfer offices are under resourced. One of the problems is stakeholders don't understand the value.
[19:39] Don talks about using business school students to get engaged with Tech Transfer.
[26:20] We need to hire university leaders that value Tech Transfer and understand how important it is.
[28:10] Prosocial Tech Transfer and defined ways of measuring it. Interviewing and surveying faculty to understand what motivates them.
[30:53] Psychological issues and the importance of champions and leadership. Tech Transfer role models are important.
[36:47] How there is a larger interest in Tech Transfer abroad. There's a much stronger international presence.
[42:09] Immediate actions include more successful marketing of Tech Transfer within the university. The responsibility falls on the leaders. Academic entrepreneurship and messaging.
[44:39] It's also been difficult to get minorities interested in Tech Transfer as a profession.
[47:37] The three key takeaways that Don would like to highlight includes whoever manages the university needs to think of Tech Transfer as a major strategic issue.
[48:58] Tech Transfer strategy asking whether it's a priority. Set institutional goals and priorities.
[49:28] If it is a priority, the resources should reflect that.
[50:16] Which modes of tech transfer should be stressed? How should it be rewarded?
[53:39] Strategies for stressing startups.
Resources:
Donald Siegel ASU
The Chicago Handbook of University Technology Transfer and Academic Entrepreneurship
VentureWell
-
Have you ever thought of storytelling as a powerful business tool? In the fast-paced world of tech transfer and startups, it absolutely is. Today's episode dives deep into the importance of storytelling – what it is and how it can be your secret weapon.
We'll be joined by Otto Pohl, a storytelling guru with a fascinating career path. Otto's a former journalist published in major publications, a seasoned entrepreneur with four startups under his belt, and a communications expert for startups. He now uses his unique blend of skills to help universities translate their groundbreaking research into successful products with real-world impact.
Curious about the magic of storytelling in business? We'll learn how Otto helps tech transfer offices craft compelling narratives that resonate with investors, partners, and anyone who needs to understand the incredible work happening at universities.
But storytelling isn't just about making things sound good. We'll also explore the line between a captivating pitch and empty promises. Otto will share his insights on the Pohl Pyramid and other powerful tools to ensure your story is not just exciting, but honest and builds genuine interest.
Get ready to unlock the power of storytelling in your business! We'll discuss Otto's amazing career journey, the science behind why stories resonate, and common mistakes to avoid. This episode is packed with actionable tips and insights you won't want to miss.
In This Episode:
[02:09] Career rewrites and how journalism and entrepreneurship fit into one bucket for Otto.
[02:43] After college, he moved to Russia to work as a photojournalist. He was a New York Times Bureau photographer.
[03:17] He also discovered so many business opportunities that he quit his job to found three companies in Moscow.
[03:34] He rotated between entrepreneurship and journalism moving to several different countries.
[04:11] We learn how stories and business meet each other.
[06:21] Storytelling is deeper and bigger and more intertwined with everything we do than most of us realize. It fundamentally creates connections between events.
[07:37] From a business perspective, the story explains why your company has meaning.
[10:54] Storytelling and the startup context or pitching. Where is the line between vision and delusion?
[12:05] When we pitch something it's a story about what we think we can make happen.
[13:11] Lying about what you already have is called fraud.
[13:35] transfer professionals need to figure out what their technology can do in their portfolio and make sure there's a story about how this thing can change the world, but do it in a way that you feel will pan out.
[14:17] Otto breaks down what good storytellers do well.
[15:05] Focus on the why.
[15:31] Otto talks about the Pohl pyramid or multi-layer of why. A good storyteller knows which level of why they want to address.
[16:54] Tech transfer professionals should care about storytelling because it will help them create a better impact.
[19:05] Shining the light on your invention allows the pyramid of benefits to cascade and unfold.
[20:03] Otto shares examples of how finding and telling the right story and why your research matters has helped tech transfer offices.
[26:46] The story is what makes a new company and its product sparkle.
[27:09] Otto shares how to communicate with different stakeholders. Work from the result backwards.
[29:45] Common mistakes tech transfer offices and early stage startups make with storytelling. The academic mindset and the business mindset aren't always on the same page.
[32:39] Storytelling is still a caveman exercise satisfying fundamental human needs.
[36:08] Storytelling isn't bad, we need to shift to a customer mindset, and embrace business not academic communications.
Resources:
Otto Pohl
Otto Pohl Core Communications
Otto Pohl LinkedIn
Sapiens: A Brief History of Humankind
Promote your TTO more Effectively” – August 13, 2024 – 12 pm EST
Thank you Scorpius BioManufacturing for sponsoring this episode of AUTM on the Air. Learn more at: scorpiusbiologics.com
-
Imagine a future where innovation knows no boundaries—where groundbreaking ideas emerge from every corner of society, regardless of race, gender, or economic background. This isn't just a dream; it's the bold vision driving the Council for Inclusive Innovation, or CI2. Fresh on the scene and launched by the U.S. Patent and Trademark Office, CI2 is spearheading a revolution in how we approach creativity and invention from historically underrepresented and under-resourced communities.
Join us as we explore the heart of CI2's mission with our special guest, Louis Boston, associate counsel for the U.S. Patent and Trademark Office (USPTO) and the acting director of CI2. Louis's impressive career is marked by a dedication to expanding American innovation through diversity. He also serves as the USPTO’s Senior Freedom of Information Act (FOIA) Officer.
He is a graduate of the Washington College of Law and a former Student Bar Association President. Louis earned an LL.M. with a specialty in contract and fiscal law from the U.S. Army Judge Advocate General’s Legal Center and School. He received his B.A. in political science from The Johns Hopkins University.
Commissioned through a four-year ROTC scholarship, Louis received an education delay to attend law school. After completing law school, he served nearly 12 years in the U.S. Judge Advocate General’s Corps. Louis is a decorated Iraq combat veteran and received numerous awards and decorations including the Bronze Star Medal and the Combat Action Badge.
Listen in as Louis shares the mission of CI2, and the exciting initiatives underway to ensure that every American has the opportunity to contribute to and benefit from innovation.
In This Episode:
[02:37] CI2, pronounced CI squared, is charged for strategizing new ways to expand American innovation by tapping into the strength of our nation's diversity and increasing opportunities for all Americans to participate.
[03:44] Louis explains the 2018 Success Act that had a report for Congress that identified the representation of under-represented groups in the patent system. They recommended a creation of a high-level Council of Industry tasked with increasing the amount of underrepresented groups involved with innovation.
[05:00] CI2 strategies includes seven initiatives including the Diversity Innovation Platform. The DI platform is a free easy to use tool that shares diversity data within an innovation ecosystem.
[06:22] There's also an innovation intern program. They also have a first-time filer expedited examination program.
[08:04] Louis talks about the community outreach campaign.
[09:59] The role of partnerships CI2 includes representatives from a variety of different sectors including private industry, non-profit organizations, academia, and federal agencies.
[11:42] Advice for universities looking to engage with CI2 or other initiatives.
[12:53] Louis shares ways where everybody can get involved in your own community to help the initiative.
[13:51] The Patent Practitioners Pro Bono Program builds on the work of the Biden Administration to open the doors to innovation across the country. Meeting people where they are is key to expanding participation in the ecosystem.
[17:42] Louis looks into the future and shares long-term goals for CI2 and how he sees the council of all being in the coming years.
[19:03] Actionable steps to foster innovation. We need to get the word out and share how IP is relevant in our daily lives.
Thank you Scorpius BioManufacturing for sponsoring this episode of AUTM on the Air. Learn more at: scorpiusbiologics.com
Resources:
Council for Inclusive Innovation (CI2)
Discovering Value: Women’s Participation In University And Commercial AI Invention
New USPTO study finds women’s participation in patenting associated with substantial economic value
National Strategy for Inclusive Innovation
-
Have you ever wondered how groundbreaking scientific discoveries make their way from the lab to the marketplace? Today, we're diving deep into the intricacies of working with industry partners, negotiating deals, managing strategic research alliances, and driving external collaborations.
Joining us today is Gaylene Anderson, who brings a wealth of knowledge and experience to the table. As Boehringer Ingelheim's US Director for Strategic Research Relationships, Gaylene is responsible for forging partnerships and pathways for external collaboration with the US Research Organization, leveraging both internal synergies and engagement with external scientific partners.
Throughout her career, Gaylene has been a champion of economic development and entrepreneurship, creating over a dozen startups and staying focused on developing relationships with investor groups and business development colleagues nationwide. In our conversation, we'll explore creating and managing partnerships, identifying scientific partners, training and support programs for researchers, and more.
In This Episode:
[02:26] If Gaylene had it to do over again, she would spend more time with the scientists to understand their world more.
[05:17] She would also spend more time on the front end before engaging with a partner.
[09:44] Tech transfer professionals should sit down with their directors and explain how they want to maximize and have the best results possible. Success breeds success.
[14:06] Before working with external partners, Gaylene has to get organized internally. She works with the scientists and department heads to understand their research needs first.
[19:30] Strategies or programs developed to foster entrepreneurship and bridge the gap to industry. She asked the dean for students interested in commercialization. She then coached these students and entered them in business competitions.
[25:12] When securing funding and investor engagement, you have to go where the opportunities and investors are.
[30:00] Budgetwise, maximize what you can. Once you have some success the money will be found to do more.
[33:39] Gaylene shares some of her experiences at Cleveland Clinic and other institutions.
[36:54] Invite tech transfer colleagues to your meetings, including them will improve your deal flow and collaborations.
[37:41] Emerging trends and shifts include people realizing that you have to be more than a licensing expert. They need to be collaboration experts.
[41:34] Common misconceptions or pitfalls when working with industry partners that tech transfer professionals should be aware of include remembering your relationships and reputation are everything. Treat each other with respect and realize not everyone knows and understands the entire contract.
[45:41] Find ways to create relationships with industry partners. Make an effort to build relationships because these contacts will be important for you someday.
Resources:
Gaylene Anderson
Gaylene Anderson LinkedIn
Scorpius Biologics
Scorpius Biologics is a sponsor of this episode.
-
Have you ever wondered what truly goes into the commercialization of a patented invention? Today we're exploring an often misunderstood aspect of tech transfer: the strategic licensing of know-how.
Know-how encompasses the vital information necessary or beneficial for the commercialization of a patented invention. While a patent license combines aspects of both federal and state law, a know-how license is governed solely by state law, as it lacks federal statutory protection.
To guide us through this intricate subject, we have Wes Blakeslee with us. Wes holds an Engineering Degree from Penn State University and a Law Degree from the University of Maryland School of Law. With over 15 years of experience at The Johns Hopkins University as an Associate General Counsel and later as Executive Director of Technology Transfer, Wes is a seasoned expert in intellectual property and business law. A Certified Licensing Professional, he is a frequent speaker at conferences and a consultant on intellectual property and business matters.
Join us as we dive deep into the complexities and strategic importance of know-how licensing with Wes Blakeslee.
In This Episode:
[01:45] Wes was an engineer with NASA before he became a lawyer. In 1982, he acquired a client that does research and development for the government. There are no patents for classified technology, so that's how he was introduced to "know-how" licensing.
[03:34] It means something you know that others don't. Know-how must be protected like a trade secret with steps taken to protect it.
[04:52] You don't want to patent a trade secret, because the records are public. Patented licenses can include "know-how".
[07:31] Describing "know-how" can include specifications. There's no specific protection for "know-how", so you have to describe the "know-how" and what it can and can't be used for. There are confidentiality provisions.
[09:24] Drafting a non-exclusive license for "know-how" is more simple than a non-exclusive license. It's critical in an exclusive license to make sure that you still have the right to use the information yourself. You have to be careful to define the field.
[12:19] The "know-how" license looks a lot like a patent license, except for the extra terms you have to know, and that there's no general legal protection.
[13:50] Describing the nature of the deal without releasing specifics. Process and product know-how licensing agreement.
[16:24] A lot of "know-how" is process-oriented and gets licensed on an annual basis.
[18:31] The goal of the negotiation is to give the other side everything they need, while preserving for your client everything that they need.
[22:00] Common obstacles include teaching them what they need without teaching them everything you know.
[26:49] Wes talks about the licensing for non-profits and hospitals.
[29:28] Almost every academic license will have a patent and "know-how" in the license.
[35:17] There should be discussion of "know-how" in the advanced licensing course. AUTM is a great resource! Licensing Executives Society is also a good resource.
Resources:
Wes Blakeslee Website
Wes Blakeslee LinkedIn
Licensing Executives Society
-
Have you ever wondered what really powers the success of tech transfer offices at universities? It’s not just the groundbreaking research or innovative technologies—it’s the relationships behind the scenes.
In today’s episode, we’re highlighting the importance of cultivating strong relationships with faculty members. These connections not only facilitate technology disclosures but also significantly boost the marketing reach and appeal of research to industry partners.
Joining us to shed light on this topic is David McClure, the Managing Director of Licensing at the Office of Research Commercialization, Texas Tech University System. David brings a wealth of experience and insight into why fostering strong faculty relationships is essential for the success of a tech transfer office.
We’ll be discussing effective strategies for initiating and maintaining engagement with faculty, the challenges and nuances of making tough decisions about researchers' inventions, and the best communication practices for managing expectations. Plus, we’ll explore how relationship-building can be seamlessly integrated into these efforts.
In This Episode:
[01:21] The importance of strong relationships with faculty for tech transfer success. We have to create a system of mutual trust where each of us will do our respective jobs.
[02:27] No invention has ever been licensed without the full support of the researcher. The feedback is very important for success.
[04:03] The key is communication. When an invention disclosure comes in it gets assigned to a licensee manager and they carry it through until a license is negotiated. Making the process transparent and showing every step to a faculty member along the way.
[05:21] They make decisions on new inventions in 60 days, but they try to do it in 30 days.
[06:48] Outsourcing assessments to a third party makes the researchers feel like everyone's on the same team.
[08:45] Maintaining engagement is important. They get a list of new faculty hires. They give them a visit and ask what they are interested in and establish a relationship from day one.
[13:42] Communicating every step along the way is an effective communication strategy. Showing your work and letting the researchers know what you're doing on their behalf is very helpful.
[15:02] They also use LinkedIn as a success story communication tool.
[19:48] They make it easy and affordable for faculty members to license their technology. The industry appreciates customer validation.
[21:03] It takes years to get a patent issued and to take a technology to market. It's a long process where you should take as many shots as possible. David and his team preach patience to new faculty members. They also use colleague examples to demonstrate the process.
[22:52] The role of training and professional development in preparing TTO staff and faculty for successful collaboration and commercialization. David tries to get them plugged into the ecosystem as quickly as possible.
[27:21] How strong faculty relationships impact the overall success and growth of a tech transfer office in the long term.
[28:12] Advice for tech transfer professionals includes critical management and building a portfolio over time. Start small and build over time. Show your work. Be patient.
Resources:
David McClure Texas Tech University
David McClure LinkedIn
-
Industry-University Partnerships are crucial for fostering innovation, addressing societal challenges, and driving economic growth. By working together, universities and industries can leverage their unique strengths to create solutions that benefit society as a whole. Today, I'm excited to be joined by an amazing panel of guests, Dr. Gayathri Srinivasan, Shahila Christie, and John D. Wilson, to discuss taking a holistic approach to these partnerships.
Dr. Gayathri Srinivasan is the Executive Director of MIT Corporate Relations, a position she has held since the beginning of February 2024. As Executive Director, Gayathri leads the growth of the Industrial Liaison Program (ILP) and the Startup Exchange, building on a roster of over 200 member companies and forging impactful connections between global business leaders and MIT faculty.
John D. Wilson is the Director of Academic Contracting at GlaxoSmithKline. John's responsibilities include aligning industrial and academic research to ensure that science, technology, and people collaborate to benefit scientific development. John sits within a research externalization group that liaisons with all research units and therapeutic areas across his organization, as well as globally.
Shahila Christie began her career in academic research focusing on small molecule drug discovery and development. Recognizing the potential for commercialization, Shahila transitioned to the entrepreneurial space by co-founding a spin-off company leveraging her research. She has consulted for university-based startups and led clinical efforts for a medical diagnostics company in oncology. In her current role at Portal Innovations, she supports the growth and development of early-stage life science technologies.
I’m excited to have Gayathri, Shahila, and John with us today to talk about these crucial partnerships.
In This Episode:
[03:02] Holistic Industry University partnership is looking at the entire Institute and enterprise for the collaboration. Research, innovation, students, and education.
[05:25] It represents a collaborative effort that spans beyond the simple technology licensing. It's a multifaceted approach that is designed to nurture.
[06:30] Approaching things as a good partner who wants to collaborate and develop science is critical.
[07:19] Identifying common goals is key for collaboration. Understanding where partners are looking for opportunities and what the challenges are is very important.
[09:56] When addressing significant societal challenges for the public good. look at what your company is good at and what the academic is good at and be proactive about reaching out and solving the issues.
[12:09] It's important to be proactive, not reactive.
[13:58] Industries are well versed in knowing where the market needs are. Universities should tap into this space to leverage their capabilities and drive Innovation forward.
[16:43] The expertise is in the academic centers and pharma is really good at developing drugs. Cutting-edge technology is coming out of academic centers and working together is the best choice for creating new drugs and solutions.
[21:23] Startups in the university ecosystem are so important for this type of development.
[24:01] Best practices for creating and maintaining communication during these crucial partnerships.
[25:33] Having a dedicated point person to champion between the two institutions is key.
[27:53] Looking for ways to leverage federal money, university input, and matching dollars from industry to develop future scientists.
[30:44] Look at societal problems and which Industries and companies are suited to solve those problems.
[34:03] We talk about sharing information to develop better technology.
[34:42] Shahila talks about how VC firms analyze investment opportunities. They evaluate university partnerships through a multifaceted lens that includes assessing the technology's potential and the university's tech transfer capabilities.
[36:45] VC firms play a vital role in bridging the gap between university technologies and their successful commercializations.
[39:17] Key considerations for pharma companies evaluating partnerships include alignment.
[44:33] For large societal questions, large partnerships and collaborations will be the answer. Government support, university research and innovation, industry collaboration and support, and the market.
[45:54] Science is moving quickly and entering a transformative era. Rapid innovation is driving pharma to look more at early stage technology.
[47:11] If the academic industry and VC work together, there will be an exponential increase in our capabilities.
Resources:
Dr. Gayathri Srinivasan Executive Director of MIT Corporate Relations
Dr. Gayathri Srinivasan LinkedIn
John D. Wilson, MS, RTTP LinkedIn
Shahila Christie LinkedIn
- Montre plus
